ChemInform Abstract: 1-(1-(4-((N-Acetyl-4-piperidinyl)oxy)-2-methoxybenzoyl)piperidin-4-yl)- 4H-3,1-benzoxazin-2(1H)-one (L-371,257): A New, Orally Bioavailable, Non-Peptide Oxytocin Antagonist.

P. D. WILLIAMS

Dep. Med. Chem., Merck Res. Lab., West Point, PA 19486, USA

B. V. CLINESCHMIDT

Dep. Med. Chem., Merck Res. Lab., West Point, PA 19486, USA

J. M. ERB

Dep. Med. Chem., Merck Res. Lab., West Point, PA 19486, USA

R. M. FREIDINGER

Dep. Med. Chem., Merck Res. Lab., West Point, PA 19486, USA

M. T. GUIDOTTI

Dep. Med. Chem., Merck Res. Lab., West Point, PA 19486, USA

E. V. LIS

Dep. Med. Chem., Merck Res. Lab., West Point, PA 19486, USA

J. M. PAWLUCZYK

Dep. Med. Chem., Merck Res. Lab., West Point, PA 19486, USA

D. J. PETTIBONE

Dep. Med. Chem., Merck Res. Lab., West Point, PA 19486, USA

D. R. REISS

Dep. Med. Chem., Merck Res. Lab., West Point, PA 19486, USA

D. F. VEBER

Dep. Med. Chem., Merck Res. Lab., West Point, PA 19486, USA

C. J. WOYDEN

Dep. Med. Chem., Merck Res. Lab., West Point, PA 19486, USA